Patents by Inventor Shadia OSHODI

Shadia OSHODI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TAURINE SUPPLEMENTED CELL CULTURE MEDIUM AND METHODS OF USE
    Publication number: 20240018467
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. TaXULne can be added to the serum-free media or chemically-defined media to incrase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Application
    Filed: September 22, 2023
    Publication date: January 18, 2024
    Inventors: Amy S. Johnson, Meghan E. Casey, Shadia Oshodi, Shawn Lawrence
  • TAURINE SUPPLEMENTED CELL CULTURE MEDIUM AND METHODS OF USE
    Publication number: 20220235318
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. Taurine can be added to the serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Application
    Filed: March 29, 2022
    Publication date: July 28, 2022
    Inventors: Amy S. JOHNSON, Meghan E. CASEY, Shadia OSHODI, Shawn M. LAWRENCE
  • Taurine supplemented cell culture medium and methods of use
    Patent number: 11312936
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. Taurine can be added to serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Grant
    Filed: August 3, 2016
    Date of Patent: April 26, 2022
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Amy S. Johnson, Meghan E. Casey, Shadia Oshodi, Shawn Lawrence
  • Taurine supplemented cell culture medium and methods of use
    Patent number: 10927342
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. Taurine can be added to the serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Grant
    Filed: January 14, 2020
    Date of Patent: February 23, 2021
    Assignee: Regeneran Pharmaceuticals, Inc.
    Inventors: Amy S. Johnson, Meghan E. Casey, Shadia Oshodi, Shawn Lawrence
  • TAURINE SUPPLEMENTED CELL CULTURE MEDIUM AND METHODS OF USE
    Publication number: 20200157492
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. Taurine can be added to the serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Application
    Filed: January 14, 2020
    Publication date: May 21, 2020
    Inventors: Amy S. JOHNSON, Meghan E. CASEY, Shadia OSHODI, Shawn LAWRENCE
  • TAURINE SUPPLEMENTED CELL CULTURE MEDIUM AND METHODS OF USE
    Publication number: 20180223249
    Abstract: The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. Taurine can be added to serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included.
    Type: Application
    Filed: August 3, 2016
    Publication date: August 9, 2018
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Amy S. JOHNSON, Meghan E. CASEY, Shadia OSHODI, Shawn LAWRENCE